Abstract:WT1 encodes a podocyte transcription factor whose variants can cause an untreatable glomerular disease in early childhood. Although WT1 regulates many podocyte genes, it is poorly understood which of them are initiators in disease and how they subsequently influence other cell‐types in the glomerulus. We hypothesised that this could be resolved using single‐cell RNA sequencing (scRNA‐seq) and ligand‐receptor analysis to profile glomerular cell–cell communication during the early stages of disease in mice harbouring an orthologous human mutation in WT1 (Wt1R394W/+). Podocytes were the most dysregulated cell‐type in the early stages of Wt1R394W/+ disease, with disrupted angiogenic signalling between podocytes and the endothelium, including the significant downregulation of transcripts for the vascular factors Vegfa and Nrp1. These signalling changes preceded glomerular endothelial cell loss in advancing disease, a feature also observed in biopsy samples from human WT1 glomerulopathies. Addition of conditioned medium from murine Wt1R394W/+ primary podocytes to wild‐type glomerular endothelial cells resulted in impaired endothelial looping and reduced vascular complexity. Despite the loss of key angiogenic molecules in Wt1R394W/+ podocytes, the pro‐vascular molecule adrenomedullin was upregulated in Wt1R394W/+ podocytes and plasma and its further administration was able to rescue the impaired looping observed when glomerular endothelium was exposed to Wt1R394W/+ podocyte medium. In comparative analyses, adrenomedullin upregulation was part of a common injury signature across multiple murine and human glomerular disease datasets, whilst other gene changes were unique to WT1 disease. Collectively, our study describes a novel role for altered angiogenic signalling in the initiation of WT1 glomerulopathy. We also identify adrenomedullin as a proangiogenic factor, which despite being upregulated in early injury, offers an insufficient protective response due to the wider milieu of dampened vascular signalling that results in endothelial cell loss in later disease. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

The Dysregulated Autophagy Signaling is Partially Responsible for Defective Podocyte Development in Wt1a Mutant Zebrafish

Kidney Organoid Modeling of WT1 Mutations Reveals Key Regulatory Paths Underlying Podocyte Development

Down-regulation of Wt1 Activates Wnt/β-catenin Signaling Through Modulating Endocytic Route of LRP6 in Podocyte Dysfunction in Vitro.

Cdc42 deficiency induces podocyte apoptosis by inhibiting the Nwasp/stress fibers/YAP pathway

Towards an understanding of kidney diseases associated with WT1 mutations

Single‐cell transcriptomics identifies aberrant glomerular angiogenic signalling in the early stages of WT1 kidney disease

The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.

Myo1e Impairment Results In Actin Reorganization, Podocyte Dysfunction, And Proteinuria In Zebrafish And Cultured Podocytes

Glomerulocystic Kidney Disease in Mice with A Targeted Inactivation of Wwtr1

CRISPR/Cas9-induced Disruption of Wt1a and Wt1b Reveals Their Different Roles in Kidney and Gonad Development in Nile Tilapia

WT1+ Glomerular Parietal Epithelial Progenitors Promote Renal Proximal Tubule Regeneration after Severe Acute Kidney Injury

MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1

Liver X Receptor Activation Induces Podocyte Injury Via Inhibiting Autophagic Activity

Novel Zebrafish Polycystic Kidney Disease Models Reveal Functions of the Hippo Pathway in Renal Cystogenesis.

Podocyte-specific deletion of ubiquitin carboxyl-terminal hydrolase L1 causes podocyte injury by inducing endoplasmic reticulum stress.

miRNA-193a-mediated WT1 suppression triggers podocyte injury through activation of the EZH2/β-catenin/NLRP3 pathway in children with diabetic nephropathy

Aquaporin‐1 Retards Renal Cyst Development in Polycystic Kidney Disease by Inhibition of Wnt Signaling

KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression

Podocyte Autophagic Activity Plays a Protective Role in Renal Injury and Delays the Progression of Podocytopathies.

RhoA Deficiency Disrupts Podocyte Cytoskeleton and Induces Podocyte Apoptosis by Inhibiting YAP/dendrin Signal

Wnt / β-catenin pathway involved in podocyte injury is regulated by UCH-L 1